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Background: Syringe-dispensing machines (SDM) provide syringes at any time even to hard-to-reach injecting drug
users (IDUs). They represent an important harm reduction strategy in large populated urban areas such as Paris. We
analyzed the performance of one of the world's largest SDM schemes based in Paris over 12 years to understand its
efficiency and its limitations, to answer public and stakeholder concerns and optimize its outputs.
Methods: Parisian syringe dispensing and exchange machines were monitored as well as their sharp disposals
and associated bins over a 12-year period. Moreover, mechanical counting devices were installed on specific
syringe-dispensing/exchange machines to record the characteristics of the exchange process.
Results: Distribution and needle exchange have risen steadily by 202% for the distribution and 2,000% for syringe
recovery even without a coin counterpart. However, 2 machines out of 34 generate 50% of the total activity of the
scheme. It takes 14 s for an IDU to collect a syringe, while the average user takes 3.76 syringes per session 20 min
apart. Interestingly, collection time stops early in the evening (19 h) for the entire night.
Conclusions: SDMs had an increasing distribution role during daytime as part of the harm reduction strategy in
Paris with efficient recycling capacities of used syringes and a limited number of kits collected by IDU. Using
counting devices to monitor Syringe Exchange Programs (SEPs) is a very helpful tool to optimize use and answer
public and stakeholder concerns.Background
The primary public health strategy to prevent the trans-
mission of blood-borne viruses such as HIV among and
from people who inject drugs has been to provide exten-
sive and free access to sterile needles and syringes. Follow-
ing the HIV epidemic among drug users in the USA,
several attempts to reduce needle and syringe sharing
were initiated to reduce the spread of the virus. Among
those, Syringe Exchange Programs (SEPs) became a main-
stream tool of harm reduction programs around the
world. Their benefits have been clearly established for in-
fectious risks [1]. Many types of SEPs have been devel-
oped, ranging from pharmacies, locally run outlets, mobile
units (vans) and syringe vending machines (SVM) or
syringe-dispensing machines (SDM) [2,3].* Correspondence: emmanuel.reynaud@ucd.ie
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distribution, and reproduction in any mediumSince the mid 1980s, harm-reduction strategies have
been criticized by local communities and stakeholders
questioning their effectiveness and their role in promoting
drug use. One way to address those critics has been to
measure their public health efficacy by following virus
prevalence among drug users and general population, be-
fore and after SEP opening or by comparing sectors with
or without SEPs [4]. But despite positive results, hostile re-
actions from local communities are still common, and a
new term as been forged to define such opposition:
‘NIMBYism’ (‘not in my back yard’) [5]. They argue that
SEPs may encourage drug consumption, develop drug
traffic, create social disorder and increase public insalu-
brities. But the critics vary greatly from one neighbour-
hood to the next, depending on social context, ethnicity
and unemployment rate, for example. Secondly, elected
representatives are questioning SEP efficiency as they in-
vest public money in those schemes and related organiza-
tions and structures. They are important supports fored Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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or answers public concerns with well-structured reports
and surveys including long-term monitoring and calcula-
tion of cost-efficiency parameters (IDU cost per year, dirty
syringe recycling rate, etc.).
Similar to soda vending machines, SDMs (or SVMs) can
deliver sterile syringes and related paraphernalia (cups,
swabs, etc.) 24 h a day and 7 days a week all year long
without supervision. They do so against money, used sy-
ringes or freely distributed coins. Those machines regu-
larly attracted a segment of the IDU population that are
not reached via SEPs or pharmacy sales [6] and a broader
range of injectors [7]. SDMs are regarded as a cost-
efficient solution to deliver syringes at any time of the day
to any type of user in comparison to pharmacies or social
workers usually submitted to time constraints. However,
there is a limited amount of literature on their effective-
ness mainly based on questionnaires [8]. SDMs have been
introduced in over a hundred European and Australian
cities [9,10]. One such harm-reduction scheme based on
SDM has been run in Paris for over a decade with 34 units
by 2014. This extensive network of units spread over a
large city with diverse neighbourhoods has attracted ex-
tensive criticisms from local communities, stakeholders
and elected representatives.
We analyze quantitatively the dynamic of an SEP using
SDMs over 12 years. In order to define precisely the
characteristics of the SDMs, we have developed counting
devices that allow us to time and quantify the exchange
process. This permits us to draw general conclusions
about the dynamic and effectiveness of the SEP to an-
swer critics and concerns in addition to improving the
SEP performance to better answer users' needs.
Methods
Syringe-dispensing machines
Three types of syringe dispensing machines were moni-
tored: distributing machines that provided a prevention
kit (named Kit+®, EDEC Laboratories, Cournon, France)
against a coin, exchanging machines that provide a coin
against a used syringe and collecting machines that do
not deliver any counterpart. The machines are of the fol-
lowing brands: AVAL (Issy-les-Moulineaux, France), MGR
(Chaux, France), Vibromat (Noyelles-les-Vermelles, France)
and Sielaff (Collégien, France). All SDMs provide Kits+®
(EDEC Laboratories). Each Kit+® contains two 1-ml syringes
with a fused 0.33 × 12.7-mm gauge needle, two 5-ml
water flasks, two alcohol swabs, two Stéricups® (a rigid
plastic container that contains one cup, one filter and one
dry swab) and one condom. Containers (EDEC Laborator-
ies and EURECA Society, Langon, France) used for syr-
inge collection are specialized infection trash collection
containers of 5-, 25- or 50-l capacity in exchanging ma-
chine and 50-l containers for syringe and trash collectionin collecting machines. The monitoring of the syringe
containers as well as the associated bins was performed as
follows. Each object was extracted with tweezers, counted
and classified by two different persons.
Counting devices
In order to monitor the syringe exchange process within
SDMs, the counting devices were specifically designed
for this project (IMPACT GmbH, Cologne, Germany).
They were optimized for Distribox and Changebox models.
Those devices were installed alternatively on particular
SDMs of interest. They record the time of every operation
of the SDM by monitoring the movement of the SDM
drawer block: used syringe insertion, coin collection,
coin insertion and prevention kit collection. All data are
recorded on a flash card. The data collection is done at
regular interval via a card reader and processed using
numerical analysis software.
Data analysis
Kits and syringe distribution in SDMs were routinely re-
corded by SAFE staff during their daily or weekly distri-
bution route using established reporting forms. All
forms were transcribed in an Excel spreadsheet, saved,
stored and backed up on a local server. Counting device
data were recorded using a card reader. The data was
saved as a text file containing date, time and unit code.
Those were converted into Excel spreadsheets, saved,
stored and backed up. The analysis was performed using
Excel analysis tools to obtain descriptive statistics, in-
cluding mean and standard deviation (SD). Finally, user
interaction data were recorded by SAFE social workers
team on site on specifically design forms then recorded
electronically at the office.
Results
History of the SAFE Parisian dispensing machine SEP
We initiated our analysis by studying the historical pro-
cesses that led to the establishment of this SEP and its
evolution over a 12-year period under different organiza-
tions and management with extensive material changes.
In Paris, the dispensing machine SEP was initiated
during the 1990s by two humanitarian organizations:
‘Médecins Sans Frontières (MSF)’ and ‘Médecins du
Monde (MDM)’. Each one developed a specific strategy.
MDM implemented dispensing machines within the
drug consumption zones, coupling distributors and ex-
changers. MSF organized a partnership with pharmacists
to install only distributors in front of their shops, to en-
courage the IDUs to enter the pharmacy and to be in
contact with health professionals (Figure 1A,B). In 2000,
MDM stopped their action, followed by MSF in 2004,
and they both donated their dispensing machines to
SAFE. This association decided to develop the program
Figure 1 The SAFE dispensing machine SEP. (A) The numbers of implementations in 2000. (B) The status of the SEP in 2004. (C) Actual SAFE
SEP by dispensing machines. (D) Activity of the SAFE SEP in 2009.
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especially near railway stations. In partnership with French
authorities (state, region and town representatives), SAFE
has evaluated all the sites to define problems, inadequacies
and technical difficulties. First, dispensing machines dis-
tributing less than 700 kits per year were moved to sites
where they were expected to perform better. Secondly,
SAFE improved the existing machines by replacing the
coupling exchanger-distributor for a sturdier version, add-
ing exchangers to distributors (MSF implementations)
and moving some machines to better new location sites.
Finally, the association further developed the implementa-
tion of dispensing machines by establishing new sites for a
better coverage of the capital city and its different quarters
(Figure 1C).
Within a few years, SAFE has improved greatly the
spatial coverage by implementing new machines in de-
pleted zones and sub-optimized regions or reorganizing
the machine distribution to reduce the distance between
users and the service provided (Figure 1C). This ap-
proach allows easier access to harm reduction equip-
ment even in less favored districts where users are hard
to reach and less inclined to interact with dedicated
harm reduction programs. However, the major part of
its activity (70%) is found on the North West quarter of
Paris city. One specific district of the Paris city centre
known as the 10th arrondissement, where two majortrain stations are located (Gare du Nord and Gare de
l'Est), represents more than 50% of the total activity, but
overall, the southern city centre activity (districts 6th,
7th, 12th, 13th, 14th, 15th and 16th) has risen and more
than doubled over the 2004 to 2012 period from 9,500
kits to 19,500 distributed and today represents 14% of
the SEP overall (Figure 1D).
The Paris-based SEP has evolved over 12 years with
nearly constant monitoring and represents a perfect set-
up to analyze long-term evolution over time of an SDM-
based SEP. Interestingly, the original dispensing machines
were replaced and moved to new locations, promoting the
coupling of exchanger with distributor.Performances of the SAFE SEP
The SAFE SEP has been monitored over a 12-year
period (1999 to 2012). The data were acquired from the
two original actors: MDM (1999–2000) and MSF (1999–
2004) as well as the monthly follow-ups performed by
SAFE staff and social workers since 2000 to 2004. Due
to the large modification and reorganization of the
implementations, we have divided our study in two
parts. Firstly, we have followed up the overall perform-
ance of the entire SEP over time. On the other hand, we
have analyzed specifically a number of sites that have
been unchanged over time.
Figure 3 Syringe distribution over time. Blue: syringe distribution,
red: syringe recycled and black line: global syringe collection.
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Distribution and needle exchange have been rising steadily
until 2007, from 51,776 to 156,451 Kits© (103,552 and
312,902 syringes, respectively) and 11,719 to 250,300 sy-
ringes (88,151 exchanged for a token and 162,149 unre-
quited) (Figure 2). This represents an increase of 202% in
distribution over 12 years (20%/year) and an increase of
2,000% recovery (up 650% for strict exchange). The whole
activity of the SAFE SEP decreased in 2008, to rise again
in 2009 up to now. In 2012, the increase for distribution is
10% over 2011. However, site-specific activity is very vari-
able, both in terms of distribution and rate of recovery. A
few sites are the exception and keep an almost constant
activity, always important (Gare du Nord, 21%; Barbès,
20%; Les Halles, 8%) or slightly less important but steady
(Sebastopol, 5%; Place d'Italie, 1.5%).Performance over time on specific sites
As mentioned above, the numbers of sites that have
remained unchanged over time is limited. However, we
have isolated eight sites that we could follow over 10 years:
Gare du Nord, Les Halles, Colonel Fabien, Chevaleret,
Bichat, Strasbourg Saint Denis, Nation and Crimée
(Figure 3). As shown previously, there has been a steady
and significant increase of kit distribution in the SAFE
SEP; however, this is not an overall increase. Gare du
Nord and Chevaleret show a correlated increase, but
not the other six sites. This pointed out a more complex
behaviour of the IDU population that required a more
precise description of the SEP at the site level rather
than the overall SEP.Figure 2 Site-to-site variation over time. Eight sites were
followed for their distribution activity over 10 years (blue: 1999, red:
2006 and green: 2012).Annual variations of syringe distribution
We took advantages of the monthly follow-up intro-
duced by SAFE up to 2009 to further analyze the SEP
characteristics. The distribution is almost constant
(Table 1 and Figure 4). However, three slight variations
can be observed. The lowest activity level occurred in
December and January, while the highest activity level
was in April and May. Those peaks can be explained by
technical as well as social parameters (see the ‘Discus-
sion’ section below). It is also interesting to notice that
the 2 months of July and August are also among the
highest months for distribution and the operation of the
SAFE team especially at the Gare du Nord machine.
This is essentially correlated with the closing down of a
nearby SEP over summer.
SDM set-up management issues
The dispensing machines can be used 24 h a day and 7
days a week but need to be refilled and looked after. The
follow-up of failures, repairs and refills is an important
measure of the overall activity of such a large set-up.
This requires the accurate recording of those events. We
have been only able to obtain the records up to 2005 (5
years). The follow-up is divided in two lines of records:
failures/repairs and supply disruptions. The latter meas-
ure represents a lack of availability (SEP related), while
the former can reflect the machine mismanagement, age
or vandalism (technical related). There was a significant
increase in decommissioned machines from 2005 to
2007, both because of supply disruptions and technical
difficulties (Figure 5). This is not simply related to the
entire set-up development, since the data weighted to
the number of devices or sites are increasing. It is firstly
an increase in the number of failures: they related pri-
marily to the aging machinery; second, to the overuse of
some of them (29% of failures relate only to the Gare du
Nord site in 2007) and finally to the poor quality of one
Table 1 Annual variation of the SAFE SEP over time
Year January February March April May June July August September October November December MEAN
2003 961.78 924.50 991.33 1,105.56 1,226.44 1,239.50 1,315.56 1,263.33 977.50 1,245.78 1,400.50 1,212.73 1,155.38
2004 1,542.00 1,473.25 1,516.00 1,340.22 1,425.78 1,337.75 1,384.89 1,374.00 1,198.75 1,423.33 1,803.75 1,259.64 1,423.28
2005 2,290.44 2,328.50 2,388.00 2,658.00 2,658.22 2,563.00 2,462.89 2,452.89 2,285.75 2,291.33 2,214.50 1,902.91 2,374.70
2006 2,077.56 2,205.50 2,282.44 2,555.33 2,747.33 2,549.25 2,684.22 2,690.67 2,820.00 2,782.44 2,718.50 2,283.09 2,533.03
2007 2,848.00 2,872.25 2,932.67 2,995.78 2,668.00 2,700.75 2,942.89 3,124.67 2,977.25 2,894.44 2,865.25 2,196.91 2,834.91
2008 2,645.56 2,750.00 2,702.89 2,706.00 2,823.78 2,685.25 2,570.44 2,530.00 2,361.50 2,408.67 2,411.50 1,904.91 2,541.71
2009 2,276.22 2,407.00 2,484.00 2,808.22 2,938.44 2,590.00 2,530.00 2,502.67 2,881.50 2,683.33 2,756.00 2,270.55 2,593.99
2010 2,312.00 2,373.00 2,518.00 2,834.00 2,984.00 2,590.00 3,135.00 2,513.00 2,881.00 1,687.00 2,761.00 2,766.00 2,612.83
2011 3,096.00 2,865.00 3,170.00 3,231.00 3,471.00 3,350.00 3,399.00 3,080.00 3,178.00 3,391.00 3,318.00 3,275.00 3,235.33
2012 3,212.00 3,163.00 3,249.00 3,444.00 3,758.00 3,766.00 3,888.00 3,651.00 3,726.00 3,483.00 3,584.00 3,742.00 3,555.50
Mean 2,326.16 2,336.20 2,423.43 2,567.81 2,670.10 2,537.15 2,631.29 2,518.22 2,528.73 2,429.03 2,583.30 2,281.37 2,486.07
Italicized values: lowest months, values in bold: highest months.
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the number of supply disruptions; they have more than
doubled between 2005 and 2007, despite an increase in
refilling tours per day and the establishment of an every-
day refilling tour. In particular, the area of Gare du Nord
suffers alone 88% of supply disruptions.Monitoring a SDM SEP
To better understand the site-by-site variation, we have
equipped distributors and exchangers with automatic
counting devices to measure the distribution flux over
time. This non-invasive strategy (invisible by the IDUs)
was designed to define the speed of the processes as well
as their extent during the day or in between distribution
or exchange actions. This allows a non-biased measure
of the number of kits per user and their behaviour quali-
tatively and quantitavely. Additionally, this can be usedFigure 4 Annual variation of the SAFE SEP over time. Due to limited m
years only.to define the distribution window per day to understand
supply disruption.
We followed two sites: Barbès and Gare du Nord for
the distribution and recycling activities. This first pilot
study was primarily intended for syringe collection (517
events). The syringe collection time in a syringe-
distributing machine is 14 s (coin against a new kit) and
18 s in the case of an SDM coupled with an exchanging
unit (dirty syringe against a coin then for a new kit).
They are very similar values. The additional 4-s differ-
ence (+28%) could be a simple effect of the number of
steps required (opening the drawer, syringe introduction,
taking the token and then collecting the kit). The time
in between two IDU syringe collection is also similar (19
min and 45 s for SDM and 23 min and 30 s for SDM +
exchanging unit (+18%)), but is relatively longer when
considering the collection time (84 and 78 s longer, re-
spectively). The number of kits taken per IDU is 1.88onthly follow-up prior to 2002, the SAFE SEP was monitored for 6
Figure 5 Evolution of the failures and repairs of the SAFE SEP
SDMs. Eight sites were followed for their distribution activity over 5
years (blue: failures, red: disruptions and green: out of order).
Table 2 Data request
Partners Frequency Data type
National initiatives




Coordination toxicomanies Monthly Statistics
User profiles
Administration
Health Regional Agency 5 times a year Statistics





Organizations 4 times a year Statistics
Data on user profile
evolution and product
for specific areas
OFDT Observatoire Francais des Drogues et Toxicomanies (French Observatory
on Drugs and Drug Addictions).
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user is 2.3 syringes. The recycling rate is 61%, while the
expected rate is 50% (one recycled syringe for one token
provides one kit containing two syringes).
The follow-up of the overall activity in Gare du Nord
and Barbès pointed out an early ending of its activity
(syringe recycling: 21 h/21 h 30 min; collection: 19 h/20
h 45 min) and a empty time slot of 15 h 30 min and 15
h 15 min, respectively. The use of counting devices on
SDMs is a very useful tool that allows the follow-up of
the distribution and recycling processes with limited
biases. This is very efficient for defining limitations, un-
derstanding problems and solving them.
Answering public concerns
Our approach using large data collection on an entire
SDM scheme over time using counting devices has been
well received by the different players involved in harm
reduction in France (national drug initiatives, local au-
thorities, etc.). SAFE has been requested to provide re-
ports to national initiatives, administrative authorities
and organizations (Table 2). SAFE has been recognized
as the main provider of information in relation to drug
use and user profile within the Paris area. The steady in-
crease in data available to the communities allows the
different partners to find answers. SAFE is now regularly
asked to provide data related to syringe distribution in
order to answer critics. For example, the day and night
monitoring of syringe exchange in various districts has
clearly demonstrated the absence of activity at nighttime as well as a need to increase SDM capacities in
some areas. Moreover, the 3.76 syringe collected per
IDU disprove the syringe traffic flagged by local police
authorities. But most of all, the high exchange rate and
recycling of used syringes demonstrate the carefulness of
the IDUs for health and safety issues!
Also, this large dataset and its related possibilities have
opened way to collaboration with several research groups,
and new initiatives are being tested. For example, SAFE is
using the SDM scheme and its knowledge of user profile
(numbers, time between users, etc.) to analyze and define
products found within the syringes with the Public Health
Laboratory at University Paris XII - Châtenay-Malabry
(unpublished). Similarly, an ongoing study is being run
with the Virology Laboratory CERVI of Pitié-Salpêtrière
Hospital, AP-HP on virus content within specific syringes
collected at well-defined spots.
Discussion
The surveys of SEPs are usually indirect [8]. They are
evaluated via large virus infection surveys that cannot
distinguish between SEP users and non-users. Another
approach is the use of questionnaire that requires not
only a trained interviewer but also willing users. This in-
troduces a limitation as such. We took advantage of a
large and well-defined SDM to test a different approach.
We combined regular monitoring activities with count-
ing devices to analyze the characteristics of such a SEP
over a 10-year period.
Harm-reduction strategies are not constant over time,
and the Parisian SEP is a clear illustration of the changes
in activities and strategies of harm-reduction policy in the
Table 3 User interaction with the SAFE team over the
year 2009














Highest activity is highlighted in italics.
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by the fusion of two related projects. This has allowed a
follow-up of this strategy and an improvement of the SEP
by promoting the coupled distributor/exchanger, relocat-
ing machines of low impact and replacing obsolete or
poor-quality machines to improve the scheme. The in-
crease in distribution as well as the recycling above the ex-
pected threshold is a positive result, but does not mean
that the SAFE SEP is fully optimal. The variation per site
is tremendous and is not fully understood. The introduc-
tion of counting device seems to provide a way to further
understand the SEP and to hopefully provide optimal
solutions.
The initial point of this study was to understand the
SAFE SEP and to provide an objective view of its results
and limitations to answer local concerns. Local authorities
are regularly arguing against this SEP. However, most of
their concerns could not be monitored previously and
were based on observations or urban legends (the SEP is
used by a limited amount of users, the SEP promotes syr-
inge disposal in public areas, etc.). The mean kit uptake by
users is 1.88, and the mean time between two collections
that indicate two different users is above 10 min. This
clearly indicates that IDUs in the Paris area only take a
limited amount of syringes. We could conclude that this is
an indication of limited shared syringes based on the lim-
ited amount of syringes taken; however, our analysis can-
not be stretched this far, and further investigation using
spectrometry and DNA-based methods will be needed to
further characterize recycled syringes in correlation with
collection. This could also be used to monitor addiction
type per site. Our results proved the extended use of the
SEP by IDU in Paris and answer objectively the local au-
thorities' concerns.
Furthermore, we observed a recycling activity of the
SEP which is above the expected threshold. And this ef-
fect increases over time. We already observed in a previ-
ous study a direct improvement of the cleanliness of the
SDM SEP environment when distributors are coupled
with exchangers [11]. It seems obvious that IDU knows
about safety and disposal and consciously recycled their
used syringes even without counterparts (coins). This re-
cycling ability is higher than diabetes patients [12] or
HVC-treated patients [13]. This result indicates a clear
understanding of the SEP by its target population and a
positive outcome that needs to be further investigated in
terms of syringe exchange in between IDUs [14].
The annual variations of syringe distribution are lim-
ited and show an almost constant distribution activity.
Only three slight variations can be observed. December
and January, the coldest months of the year, show the
lowest activity level, and we hypothesized a correlation
between the slight drop of activity and the weather that
may block machines (frozen drawers, etc.) and the effecton IDUs (susceptibility to cold when in need). This is
partially confirmed by the limited number of IDUs met by
the street team of SAFE (Table 3). The highest activity
level is in April/May and July/August. The former increase
in activity appears in a period with high number of public
holidays (1st, 8th, 22nd, etc.) that limits access to other
non-SDM SEPs and pharmacies. Also, the higher number
of music festivals especially the electronic and techno
music scenes are well known to attract IDUS, and so plan-
ning of drug consumption outside urban areas could lead
to a tendency to stock kits prior to the event. Secondly,
the July/August peak could be a side effect of the holiday
seasons and the reduction of non-SDM-operated SEPs
and pharmacies.
Interestingly, the SAFE network data are slightly differ-
ent from other national drug initiatives or local associa-
tions, which are probably in relation to the fact that the
SDM set-up is a non-discriminatory system that attracts
users outside the normal framework. We believe this is a
more representative vision of injection practice. Moreover,
the SDM set-up generates very large datasets within the
1,000-count range and over and so significantly higher
than questionnaire-based studies. This provides better sta-
tistics and larger cohort study with limited bias.
The use of counting devices to monitor a SEP is the
first time in the world; we are aware this has been done.
This objective and innovative approach gave clear results
concerning distribution rate and also distribution time
window. Moreover, it illustrates our strategy. We have
already observed an increase of supply disruptions in
several sites, and public concerns pointed out an extensive
use of the SDM during the night. However, we observed
by monitoring heavily used sites (Gare du Nord and
Barbes) a limited time window of distribution that ends
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This disproves criticisms by local authorities that SDMs
are heavily used at night and generate noise around ma-
chines, leading to neighbourhood complaints. But it can
be seen as use of the SDMs by a population with a regular
daily activity (workers, civil servants, etc.) that plan their
syringe collection as part of their daily routine before leav-
ing for the suburban areas of Paris. But it may point out
towards a failure of the SAFE SEP to perform 24 h a day
and 7 days a week. Already, SAFE has implemented a
number of corrective measures:
– Installation of dispensing machines of greater
capacity in the Gare du Nord and Gare de l'Est.
This has significantly improved the issue of supply
disruptions (514 in 2007 against 19 in 2009), but
continuous monitoring is currently ongoing to
define the new time window of distribution and the
efficiency of a higher distribution capacity
– Gradual replacement of aging or obsolete machines,
which has reduced the number of failures (570 in
2007 against 420 in 2009) and the number of
technical interventions (1,202 in 2007 against
916 in 2009).
However, the disruption difficulties are not resolved be-
cause the disruptions now occur at scattered sites and ir-
regularly, making the implementation of corrective actions
difficult. Our approach is driven by the need to under-
stand syringe distribution and recycling protocols to de-
sign the best strategy, and monitoring is an essential step
to provide the highest standard of syringe accessibility.
Several points are essential: shortest distance of an IDU to
a machine, free products and multiplication of coin collec-
tion point (from 20 to 500), and the numbers we obtain
seem to validate our strategic choices. It is important to
use SDMs in our case as we can complement existing
SEPs even during holidays and at nights and offer an alter-
native to IDUs including the non-French speaking group.
Our study took advantage of a well-developed SDM-
based SEP to dissect the syringe/exchange distribution
processes and to objectively analyze its efficiency. The use
of simple counting devices allowed us not only to provide
data to the SEP operator (SAFE) to better design their sys-
tem but also to understand its limits (limited night distri-
bution/machine capacity, etc.) and answer public concern
(limited kit per IDU and higher recycling activity). Overall,
this study demonstrates the need to monitor SEP activities
to study harm-reduction strategies, answer public and pol-
itic concerns, and to develop new protocols.
Conclusions
This report represents an unprecedented long-term ana-
lysis of a SDM SEP. Such a long and precise survey is asource of information to answer public and political
concerns. It is also a valuable source of information for
SEP curators in order to optimize their activities and
better meet the needs of their users. Finally, it demon-
strates the power of simpler and cheaper approaches to
extract useful information from everyday use of ma-
chines and provide quantitative data to management,
local authorities and police forces. We currently are de-
veloping our initial approach in combination with chem-
ical and biological analyses [15] to further dissect the
Parisian IDU population in regard to their consumption,
needle sharing behaviour and infectious status down to
the local scale.
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